Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Abbott Laboratories (NY: ABT )

117.66 -0.47 (-0.40%)
Streaming Delayed Price Updated: 11:49 AM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
40 41 Next >
How Is The Market Feeling About Abbott Laboratories?
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.8% since its last report. The company recently reported that it has 12.79 million shares sold short, which is 0... 
Via Benzinga
US Lawmakers Reveal FDA Emergency Funds Bill To Tackle Baby Formula Shortage: Reuters
Via Benzinga
Where Abbott Laboratories Stands With Analysts
Analysts have provided the following ratings for Abbott Laboratories (NYSE:ABT) within the last quarter: 
Via Benzinga
Nano Dimension (NNDM) Stock Gains 10% on Share Buyback News
Nano Dimension (NNDM) stock is rising higher on Tuesday after the manufacturing company announced a new share buyback program. 
Via InvestorPlace
ABT Stock Climbs as Abbott Reaches a Baby Formula Deal With the FDA
ABT stock is climbing on reports that Abbott has reached a deal to restart baby formula production at its Sturgis, Michigan plant. 
Via InvestorPlace
Morning Brief: Top Financial Stories Dominating on Tuesday, May 17
Reuters KKR To Scoop This Power Company At 36% Premium 
Via Benzinga
Expert Ratings for Abbott Laboratories
Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
'Mother Like' Kim Jong-Un Personally Tastes Baby Formula To Ensure Quality: North Korea Mocks US Shortages
Taking a dig at the U.S. formula shortages, a bizarre news article from North Korean state media randomly claimed that Kim Jong Un personally oversaw the perfection of the nation's baby formula... 
Via Benzinga
US Baby Formula Crisis Could See Some Relief As FDA, Abbott Agree On Deal
The baby formula shortage that has morphed into a crisis in the U.S. could soon see some relief following an agreement between market leader Abbott Laboratories (NYSE: ABT) and the Food and Drug... 
Via Benzinga
Abbott Spent $5B On Stock Buybacks Instead Of Fixing Its Baby Formula Factory
The fear of not knowing where your child’s next meal comes from is something that no parent should face. But, because of a recall of Abbott Laboratories’ (NYSE: ABT) Similac and other popular baby... 
Via Benzinga
Bette Midler Panned For Breastfeeding Remark In Wake Of Baby Formula Shortage
Singer and actress Bette Midler received a round of boos on Twitter Inc (NYSE: TWTR) after volunteering the idea that American women impacted by the ongoing baby formula shortage turn to... 
Via Benzinga
Could This Technology Hold The Potential To Help Prevent Alcohol-Related Accidents And Deaths?
Photo by Vinicius "amnx" Amano on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Abbott Clocks Q1 COVID-19 Test Sales Of $3.3B, Reaffirms FY22 EPS Outlook
Via Benzinga
Biden Says Baby Formula Shortage To Ease In Weeks With Increased Imports: Reuters
The U.S. is working with manufacturers to increase imports of baby formula, Biden told reporters. "We're going to be getting significantly more formula on shelves in a matter of weeks or less," he... 
Via Benzinga
Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report
Via Benzinga
Insider Weekends: "Adjusted" Insider Buying Increased Last Week With Insiders Purchasing $176.54 Million Of Stock
During a highly volatile week for markets, we saw insiders step up and purchase shares, although in aggregate it looked like both insider buying and selling declined compared to... 
Via Benzinga
Here's How Much $100 Invested In Abbott Laboratories 5 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 5 years by 8.78% on an annualized basis producing an average annual return of 20.13%. Currently, Abbott Laboratories has a... 
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 9.21% since its last report. The company recently reported that it has 12.10 million shares sold short, which is... 
Via Benzinga
Abbott Strengthens Its Connected Care Technologies With Latest Neurosphere™ Mypath™ Digital Health App
SOURCE: Abbott 
Via 3BL Media
How is it going with the Big Biopharma Earnings Week?
Abbott and JNJ kicked off healthcare earnings last week and the results were just OK. 
Via Talk Markets
EXCLUSIVE: Verano CIO Aaron Miles Says Company Is 'Strategically Building' As Crucial Markets Come Online
Verano Holdings Corp (OTC: VRNOF) CIO Aaron Miles tells Benzinga that he and the Chicago-based MSO have been able to grow in the often tumultuous cannabis market through market experience and strategic... 
Via Benzinga
3 Dividend Stocks for Value Investors Seeking Regular Income
The list includes high dividend paying stocks that are growing at a steady rate, suitable for income-seeking investors. 
Via InvestorPlace
Market Rally Hits Resistance; Netflix Crashes, Tesla, Lockheed, United Airlines, Alcoa In Focus: Weekly Review
The major indexes sold off after moving up to or above key levels. 
Via Investor's Business Daily
19 Dividend Stocks That Pay In February, May, August And November
Looking to fill in your dividend calendar? These top dividend stocks pay quarterly. 
Via Talk Markets
7 Stocks to Buy If You Think Inflation Is Topping Out
Some analysts believe that the market may have seen peak inflation. Here are seven stocks to buy if inflation is at or near its peak. 
Via InvestorPlace
What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings
Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically,... 
Via Benzinga
Homebuilders Hammer Away After Tuesday's Rally As Yields Tick Lower
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. (Wednesday Market Open) Equity index futures pointed to a... 
Via Benzinga
Abbott Labs First-Quarter Results Top Estimates, Earnings Outlook Short
ABT stock fell early Wednesday as it reported quarterly results that beat estimates, driven by $3.3 billion in sales of its COVID-19 tests. 
Via Investor's Business Daily
Benzinga's Daily Brief On Trending Tickers For April 20, 2022: Procter & Gamble, Lululemon, Netflix, And More
Benzinga’s “Daily Brief On Trending Tickers” features the top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. 
Via Benzinga
Abbott Laboratories: Q1 Earnings Insights
Abbott Laboratories (NYSE:ABT) reported its Q1 earnings results on Wednesday, April 20, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.